The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. MAIA Biotechnology Inc shares valued at $50,000 were purchased by Smith Stan on Jun 03 ’25. At $1.50 per share, Smith Stan acquired 33,333 shares. The insider’s holdings grew to 1,305,059 shares worth approximately $2.32 million following the completion of this transaction.
Also, Guerrero Ramiro purchased 20,000 shares, netting a total of over 30,000 in proceeds. Following the buying of shares at $1.50 each, the insider now holds 588,218 shares.
Before that, Smith Stan had added 66,666 shares to its account. In a trade valued at $99,999, the Director bought MAIA Biotechnology Inc shares for $1.50 each. Upon closing the transaction, the insider’s holdings increased to 66,666 shares, worth approximately $2.26 million.
Analyzing MAIA Stock Performance
On last trading session,, MAIA Biotechnology Inc [AMEX: MAIA] rose 4.09% to $1.78. The stock’s lowest price that day was $1.74, but it reached a high of $1.9 in the same session. During the last five days, there has been a drop of approximately -7.77%. Over the course of the year, MAIA Biotechnology Inc shares have dropped approximately -51.50%.
Support And Resistance Levels for MAIA Biotechnology Inc (MAIA)
RSI (Relative Strength Index) is 48.37 on the 14-day chart, showing neutral technical sentiment.
Is MAIA Biotechnology Inc subject to short interest?
Stocks of MAIA Biotechnology Inc saw a sharp steep in short interest on 2025-06-13 dropping by -0.17 million shares to 0.39 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 0.56 million shares. A decline of -42.51% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 1.52 of the overall float, the days-to-cover ratio (short ratio) decline to 1.52.
